Based on 124 Wall Street analysts offering 12 month price targets to T. Rowe Price Mid-Cap Growth Fund, Inc. holdings in the last 3 months. The average price target is $119.43 with a high forecast of $138.36 and a low forecast of $97.52. The average price target represents a 16.71% change from the last price of $102.33.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"96":"$96","139":"$139","106.75":"$106.8","117.5":"$117.5","128.25":"$128.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":138.359,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$138.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":119.431,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$119.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":97.521,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$97.52</span>\n  </div></div>","useHTML":true}}],"tickPositions":[96,106.75,117.5,128.25,139],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2024","6":"Jul<br/>2024","9":"Oct<br/>2024","12":"Jan<br/>2025","25":"Jan<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,99.73,102.70146153846154,105.67292307692308,108.64438461538462,111.61584615384616,114.5873076923077,117.55876923076923,120.53023076923077,123.50169230769231,126.47315384615385,129.4446153846154,132.41607692307693,135.38753846153847,{"y":138.359,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,99.73,101.24546153846154,102.76092307692308,104.27638461538461,105.79184615384615,107.30730769230769,108.82276923076924,110.33823076923076,111.85369230769231,113.36915384615385,114.88461538461539,116.40007692307692,117.91553846153846,{"y":119.431,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,99.73,99.56007692307692,99.39015384615385,99.22023076923077,99.0503076923077,98.88038461538461,98.71046153846154,98.54053846153846,98.37061538461539,98.20069230769231,98.03076923076924,97.86084615384615,97.69092307692308,{"y":97.521,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":99.13,"date":1704153600000,"info":"<div>Price: <b>$99<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":101.2,"date":1706745600000,"info":"<div>Price: <b>$101<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":106.7,"date":1709251200000,"info":"<div>Price: <b>$107<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":107.98,"date":1711929600000,"info":"<div>Price: <b>$108<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":101.89,"date":1714521600000,"info":"<div>Price: <b>$102<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":103.23,"date":1717372800000,"info":"<div>Price: <b>$103<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":102.77,"date":1719792000000,"info":"<div>Price: <b>$103<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":105.28,"date":1722470400000,"info":"<div>Price: <b>$105<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":106.26,"date":1725321600000,"info":"<div>Price: <b>$106<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":108.68,"date":1727740800000,"info":"<div>Price: <b>$109<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":108.67,"date":1730419200000,"info":"<div>Price: <b>$109<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":115.97,"date":1733097600000,"info":"<div>Price: <b>$116<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":99.73,"date":1735776000000,"info":"<div>Price: <b>$100<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$138.36

Average Price Target$119.43

Lowest Price Target$97.52

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

RPMGX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

IONS

Ionis Pharmaceuticals Inc.

10 Buy

5 Hold

0 Sell

Moderate Buy

$60.71

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CYTK

Cytokinetics

10 Buy

2 Hold

0 Sell

Strong Buy

$85.38

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PCVX

Vaxcyte, Inc.

8 Buy

0 Hold

0 Sell

Strong Buy

$146.57

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CRSP

Crispr Therapeutics

10 Buy

8 Hold

2 Sell

Moderate Buy

$65.75

xxxxxxxxxxxxxxxxxxxxxxxxxxx

BIIB

Biogen Inc.

11 Buy

13 Hold

0 Sell

Moderate Buy

$225.37

RPMGX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

THS

TreeHouse Foods

0 Buy

6 Hold

0 Sell

Hold

$32.60

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RRC

Range Resources

5 Buy

12 Hold

2 Sell

Hold

$38.44

xxxxxxxxxxxxxxxxxxxxxxxxxxx

LSCC

Lattice Semiconductor Corporation

9 Buy

1 Hold

1 Sell

Moderate Buy

$55.50

xxxxxxxxxxxxxxxxxxxxxxxxxxx

LNG

Cheniere Energy Inc.

14 Buy

0 Hold

0 Sell

Strong Buy

$244.21

xxxxxxxxxxxxxxxxxxxxxxxxxxx

EQT

EQT Corp

12 Buy

8 Hold

0 Sell

Moderate Buy

$51.95

RPMGX Mutual Fund FAQ

What is RPMGX’s average 12-month price target, according to analysts?

Based on analyst ratings, T. Rowe Price Mid-Cap Growth Fund, Inc.’s 12-month average price target is $119.43.

What is RPMGX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for RPMGX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is RPMGX a Buy, Sell or Hold?

T. Rowe Price Mid-Cap Growth Fund, Inc. has a consensus rating of Moderate Buy which is based on 112 buy ratings, 12 hold ratings and 0 sell ratings.

What is T. Rowe Price Mid-Cap Growth Fund, Inc.’s price target?

The average price target for T. Rowe Price Mid-Cap Growth Fund, Inc. is $119.43. This is based on 124 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $138.36 ,the lowest forecast is $97.52. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about T. Rowe Price Mid-Cap Growth Fund, Inc.?

T. Rowe Price Mid-Cap Growth Fund, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 124 Wall Streets Analysts.

How can I buy shares of RPMGX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing